Prelude Therapeutics Inc is a clinical-stage biopharmaceutical company based in Wilmington, DE, specializing in the design and development of novel, small molecule therapies for cancer treatment. With a focus on precision oncology, their pipeline includes multiple first-in-class programs in clinical trials that target the key drivers of cancer cell growth and resistance.
Driven by a bold scientific approach, Prelude Therapeutics combines expertise in cancer biology, medicinal chemistry, and drug development to translate scientific discoveries into potential treatments that offer hope to patients with cancer. Their innovative medicines aim to improve the lives of people with cancer by precisely targeting the underlying mechanisms of the disease.
Generated from the website